Single-nucleus expression characterization of non-enhancing region of recurrent high-grade glioma.
Saved in:
| Title: | Single-nucleus expression characterization of non-enhancing region of recurrent high-grade glioma. |
|---|---|
| Authors: | Patel KS; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Tessema KK; The Intellectual and Developmental Disabilities Research Center and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Kawaguchi R; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Dudley L; The Intellectual and Developmental Disabilities Research Center and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Alvarado AG; The Intellectual and Developmental Disabilities Research Center and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Muthukrishnan SD; The Intellectual and Developmental Disabilities Research Center and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Perryman T; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Hagiwara A; UCLA Brain Tumor Imaging Laboratory (BTIL), Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Swarup V; Department of Neurobiology and Behavior, UCI School of Biological Sciences, Irvine, California, USA., Liau LM; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Wang AC; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Yong W; Department of Pathology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Geschwind DH; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Nakano I; Department of Neurosurgery, Hokuto Social Medical Corporation, Hokuto Hospital, Hokuto, Japan., Goldman SA; Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, New York, USA.; Faculty of Health and Medical Sciences, Center for Translational Neuromedicine, University of Copenhagen, Copenhagen, Denmark., Everson RG; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Ellingson BM; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Kornblum HI; The Intellectual and Developmental Disabilities Research Center and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Departments of Pediatrics, Psychiatry, and Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2024 Jan 25; Vol. 6 (1), pp. vdae005. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2632-2498 |
|---|---|
| DOI: | 10.1093/noajnl/vdae005 |
